nGageIT: Breathing life into cancer diagnostics

How nGageIT's breath-based diagnostic enables rapid, early detection of cancer

nGageIT is developing breath-based cancer diagnostics for early detection of tumors at the point of care, without the time-consuming lab analysis that comparable technologies require.

CEO Raj Reddy told BioCentury the inability of physicians to diagnose cancers early contributes to poor survival rates. To improve those odds, he began exploring exhaled volatile organic compounds (VOCs) as cancer markers. The compounds and their connection to

Read the full 638 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE